1. A New Benzopyranyl Cadenane Sesquiterpene and Other Antiplasmodial and Cytotoxic Metabolites from Cleistochlamys kirkii .
- Author
-
Nyandoro SS, Maeda G, Munissi JJE, Gruhonjic A, Fitzpatrick PA, Lindblad S, Duffy S, Pelletier J, Pan F, Puttreddy R, Avery VM, and Erdélyi M
- Subjects
- Annonaceae metabolism, Humans, Malaria drug therapy, Molecular Conformation, Molecular Structure, Parasitic Sensitivity Tests, Spectrum Analysis, Annonaceae chemistry, Antimalarials chemistry, Antimalarials pharmacology, Plant Extracts chemistry, Plant Extracts pharmacology, Polycyclic Sesquiterpenes chemistry, Polycyclic Sesquiterpenes pharmacology
- Abstract
Phytochemical investigations of ethanol root bark and stem bark extracts of Cleistochlamys kirkii (Benth.) Oliv. (Annonaceae) yielded a new benzopyranyl cadinane-type sesquiterpene (cleistonol, 1 ) alongside 12 known compounds ( 2 - 13 ). The structures of the isolated compounds were established from NMR spectroscopic and mass spectrometric analyses. Structures of compounds 5 and 10 were further confirmed by single crystal X-ray crystallographic analyses, which also established their absolute stereochemical configuration. The ethanolic crude extract of C. kirkii root bark gave 72% inhibition against the chloroquine-sensitive 3D7-strain malaria parasite Plasmodium falciparum at 0.01 μg/mL. The isolated metabolites dichamanetin, ( E )-acetylmelodorinol, and cleistenolide showed IC
50 = 9.3, 7.6 and 15.2 μM, respectively, against P. falciparum 3D7. Both the crude extract and the isolated compounds exhibited cytotoxicity against the triple-negative, aggressive breast cancer cell line, MDA-MB-231, with IC50 = 42.0 μg/mL (crude extract) and 9.6-30.7 μM (isolated compounds). Our findings demonstrate the potential applicability of C. kirkii as a source of antimalarial and anticancer agents.- Published
- 2019
- Full Text
- View/download PDF